| |
|
|
|
Evofem Biosciences Inc  
|
|
2.93 0.1 (0.04%) |
01-25 16:00 |
|
Open: |
2.92 |
Pre close: |
2.83 |
Target:
|
3.61 
|
|
High: |
3.09 |
Low: |
2.87 |
Resistance:
|
3.09
3.61
|
|
Volume: |
3,753,631 |
Market Cap: |
238M |
Support:
|
2.43
2.03
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.79
|
MACD |
MACD(12,26):
|
0.13 |
|
MA(20): |
2.62 |
Signal(12,26,9): |
0.11 |
|
MA(100): |
2.49  |
Stochastic Oscillator |
%K(14,3):
|
83.90 |
|
MA(250): |
3.56 |
%D(3): |
80.18 |
|
Average Volume(K) |
3-Month: |
252084
|
52-Week |
High:
|
7.21 |
|
10-Days: |
281527 |
Low: |
1.91 |
|
RSI |
RSI(14):
|
73.01 |
Change(%): |
-44.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.925 |
Return on Equity (ttm) |
-356.0 |
Shares Out. (M) |
81.28 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-66.5 |
Shares Float (M) |
80.10 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.65 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
45.00 |
|
Forward EPS |
-1.990 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
9570 |
|
Book Value (p.s.) |
0.500 |
EBITDA (p.s.) |
-0.988 |
P/E |
-1.52 |
|
Sales Per Share |
0.003 |
Qtrly Earnings Growth |
0.00 |
P/BV |
5.86 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-79.20 |
P/S |
856.66 |
|
Operating Margin |
-28973.02 |
Levered Free Cash Flow
(M) |
-50.94 |
P/CF |
-3.01 |
|
|
|
|
|
|
